Gadolinium-enhanced, vessel-tracking, two-dimensional coronary MR angiography: Single-dose arterial-phase vs. Delayed-phase imaging

Vincent B. Ho, Thomas K F Foo, Andrew E. Arai, Steven D. Wolff

Research output: Contribution to journalArticle

Abstract

The purposes of our study were to investigate the benefits of using a single dose of an extracellular contrast agent for coronary magnetic resonance angiography (CMRA) and to determine the relative benefits of arterial-phase vs. delayed-phase image acquisition. The right coronary artery was imaged in 10 healthy adults using a breath-hold, two-dimensional fast gradient echo pulse sequence designed for vessel tracking (multiphase, multislice image acquisition). Pre- and postcontrast CMRA was performed. Postcontrast imaging consisted of arterial- and delayed-phase CMRA following a 15 mL bolus (single dose) of contrast media and of delayed-phase imaging following a cumulative 45 mL contrast dose (triple dose). Contrast-enhanced CMRA provided a significantly higher (P <0.001) signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) than noncontrast CMRA. CNR was highest for single-dose arterial-phase CMRA (13.1 ± 4.5) and triple-dose delayed-phase CMRA (13.0 ± 4.8), followed by single-dose delayed-phase CMRA (8.4 ± 3.5) and noncontrast CMRA (4.2 ± 1.8). Single-dose arterial-phase CMRA provided the best visualization of the distal right coronary artery and was preferred for blinded physician assessments. We concluded that utilization of a single dose of extracellular contrast media improves CMRA, especially if timed for arterial-phase imaging.

Original languageEnglish (US)
Pages (from-to)682-689
Number of pages8
JournalJournal of Magnetic Resonance Imaging
Volume13
Issue number5
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Magnetic Resonance Angiography
Gadolinium
Coronary Angiography
Contrast Media
Noise
Coronary Vessels
Signal-To-Noise Ratio
Physicians

Keywords

  • Arteries, coronary
  • Arteries, MR
  • Coronary vessels, MR
  • Gadolinium
  • Magnetic resonance, contrast enhancement
  • Magnetic resonance, vascular studies

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Gadolinium-enhanced, vessel-tracking, two-dimensional coronary MR angiography : Single-dose arterial-phase vs. Delayed-phase imaging. / Ho, Vincent B.; Foo, Thomas K F; Arai, Andrew E.; Wolff, Steven D.

In: Journal of Magnetic Resonance Imaging, Vol. 13, No. 5, 2001, p. 682-689.

Research output: Contribution to journalArticle

Ho, Vincent B. ; Foo, Thomas K F ; Arai, Andrew E. ; Wolff, Steven D. / Gadolinium-enhanced, vessel-tracking, two-dimensional coronary MR angiography : Single-dose arterial-phase vs. Delayed-phase imaging. In: Journal of Magnetic Resonance Imaging. 2001 ; Vol. 13, No. 5. pp. 682-689.
@article{f5a61be3ecfb458f90f748147da93c8a,
title = "Gadolinium-enhanced, vessel-tracking, two-dimensional coronary MR angiography: Single-dose arterial-phase vs. Delayed-phase imaging",
abstract = "The purposes of our study were to investigate the benefits of using a single dose of an extracellular contrast agent for coronary magnetic resonance angiography (CMRA) and to determine the relative benefits of arterial-phase vs. delayed-phase image acquisition. The right coronary artery was imaged in 10 healthy adults using a breath-hold, two-dimensional fast gradient echo pulse sequence designed for vessel tracking (multiphase, multislice image acquisition). Pre- and postcontrast CMRA was performed. Postcontrast imaging consisted of arterial- and delayed-phase CMRA following a 15 mL bolus (single dose) of contrast media and of delayed-phase imaging following a cumulative 45 mL contrast dose (triple dose). Contrast-enhanced CMRA provided a significantly higher (P <0.001) signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) than noncontrast CMRA. CNR was highest for single-dose arterial-phase CMRA (13.1 ± 4.5) and triple-dose delayed-phase CMRA (13.0 ± 4.8), followed by single-dose delayed-phase CMRA (8.4 ± 3.5) and noncontrast CMRA (4.2 ± 1.8). Single-dose arterial-phase CMRA provided the best visualization of the distal right coronary artery and was preferred for blinded physician assessments. We concluded that utilization of a single dose of extracellular contrast media improves CMRA, especially if timed for arterial-phase imaging.",
keywords = "Arteries, coronary, Arteries, MR, Coronary vessels, MR, Gadolinium, Magnetic resonance, contrast enhancement, Magnetic resonance, vascular studies",
author = "Ho, {Vincent B.} and Foo, {Thomas K F} and Arai, {Andrew E.} and Wolff, {Steven D.}",
year = "2001",
doi = "10.1002/jmri.1096",
language = "English (US)",
volume = "13",
pages = "682--689",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Gadolinium-enhanced, vessel-tracking, two-dimensional coronary MR angiography

T2 - Single-dose arterial-phase vs. Delayed-phase imaging

AU - Ho, Vincent B.

AU - Foo, Thomas K F

AU - Arai, Andrew E.

AU - Wolff, Steven D.

PY - 2001

Y1 - 2001

N2 - The purposes of our study were to investigate the benefits of using a single dose of an extracellular contrast agent for coronary magnetic resonance angiography (CMRA) and to determine the relative benefits of arterial-phase vs. delayed-phase image acquisition. The right coronary artery was imaged in 10 healthy adults using a breath-hold, two-dimensional fast gradient echo pulse sequence designed for vessel tracking (multiphase, multislice image acquisition). Pre- and postcontrast CMRA was performed. Postcontrast imaging consisted of arterial- and delayed-phase CMRA following a 15 mL bolus (single dose) of contrast media and of delayed-phase imaging following a cumulative 45 mL contrast dose (triple dose). Contrast-enhanced CMRA provided a significantly higher (P <0.001) signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) than noncontrast CMRA. CNR was highest for single-dose arterial-phase CMRA (13.1 ± 4.5) and triple-dose delayed-phase CMRA (13.0 ± 4.8), followed by single-dose delayed-phase CMRA (8.4 ± 3.5) and noncontrast CMRA (4.2 ± 1.8). Single-dose arterial-phase CMRA provided the best visualization of the distal right coronary artery and was preferred for blinded physician assessments. We concluded that utilization of a single dose of extracellular contrast media improves CMRA, especially if timed for arterial-phase imaging.

AB - The purposes of our study were to investigate the benefits of using a single dose of an extracellular contrast agent for coronary magnetic resonance angiography (CMRA) and to determine the relative benefits of arterial-phase vs. delayed-phase image acquisition. The right coronary artery was imaged in 10 healthy adults using a breath-hold, two-dimensional fast gradient echo pulse sequence designed for vessel tracking (multiphase, multislice image acquisition). Pre- and postcontrast CMRA was performed. Postcontrast imaging consisted of arterial- and delayed-phase CMRA following a 15 mL bolus (single dose) of contrast media and of delayed-phase imaging following a cumulative 45 mL contrast dose (triple dose). Contrast-enhanced CMRA provided a significantly higher (P <0.001) signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) than noncontrast CMRA. CNR was highest for single-dose arterial-phase CMRA (13.1 ± 4.5) and triple-dose delayed-phase CMRA (13.0 ± 4.8), followed by single-dose delayed-phase CMRA (8.4 ± 3.5) and noncontrast CMRA (4.2 ± 1.8). Single-dose arterial-phase CMRA provided the best visualization of the distal right coronary artery and was preferred for blinded physician assessments. We concluded that utilization of a single dose of extracellular contrast media improves CMRA, especially if timed for arterial-phase imaging.

KW - Arteries, coronary

KW - Arteries, MR

KW - Coronary vessels, MR

KW - Gadolinium

KW - Magnetic resonance, contrast enhancement

KW - Magnetic resonance, vascular studies

UR - http://www.scopus.com/inward/record.url?scp=0035040177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035040177&partnerID=8YFLogxK

U2 - 10.1002/jmri.1096

DO - 10.1002/jmri.1096

M3 - Article

C2 - 11329189

AN - SCOPUS:0035040177

VL - 13

SP - 682

EP - 689

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 5

ER -